January 2025
Matters of the heart – Cardiac arrest vs Heart attack
Many medical dramas would lead you to believe that a heart attack and cardiac arrest are two names for the same condition but, as you may have guessed, this is not the case. Whilst both are certainly conditions that affect the heart, one pertains to a circulation issue and the other is an electrical issue.
January 2025
A toolkit for living a good life
Anne-Maree Wilton was first diagnosed with ovarian cancer in January 2018 but she hasn't let that stop her from living a full and beautiful life.
December 2024
Discovery opens door for new cancer drugs
Associate Professor Mark Chong is leading a project – supported by a $50,000 Tour de Cure grant – to develop a new class of drugs to inhibit certain microRNAs within the immune system as a novel immunotherapy to treat cancer.
December 2024
SVI welcomes new Foundation Chair
Jeremy was educated at Xavier College and the University of Melbourne. He enjoyed a diverse legal practice, specialising in property related matters, particularly town planning. He was a member of The Bar’s Ethics Committee for five years and Chairman of the committee that managed Foley’s List, Barristers, and a director, for nine years.
December 2024
New funding in support of type 1 diabetes research
Head of SVI's Human Immunology Lab Associate Professor Stuart Mannering has received $150k grant from JDRF for the commercialisation of his research under their new program called SPARC.
November 2024
Funds to better understand Friedreich ataxia drug
Associate Professor Shiang (Max) Lim, of SVI's O’Brien Department, has been awarded funding from the Friedreich’s Ataxia Research Alliance (FARA) to better understand the effect of omaveloxolone – a recently FDA-approved drug – on heart disease in people with Friedreich ataxia.
November 2024
Hidden 3-D atomic structure revealed – drugs for Alzheimer’s a step closer
A new study involving shooting X-rays at crystals has uncovered the precise three-dimensional structure of an enzyme associated with Alzheimer's disease, allowing researchers to now use powerful computers to discover drug-like molecules to treat the disease.
November 2024
Stars shine at soirée
The Rising Star program provides critical support to early-mid career researchers, giving them the resources they need to excel in their research and make a lasting impact, said SVI Foundation Board Chair and Rising Star founder, Karen Inge.